Skip to content
Clinical Trials – home

Specderm Poznanska Sp. j.

Research site

Poland Ul. Prezydenta Ryszarda Kaczorowskiego 7/u 50, 15-375 Bialystok, Poland

  • 8 trials recruiting
  • Psoriasis · Acne · Type 2 diabetes mellitus
  • Adults and children

About Specializations

Specderm Poznanska Sp. j. in Bialystok, Poland specialises in clinical trials of conditions such as Psoriasis, Acne, Type 2 diabetes mellitus, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology

The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions such as plaque psoriasis and chronic hand eczema. Through rigorous clinical trials, the center evaluates the efficacy and safety of novel therapeutic agents, contributing significantly to the understanding and management of these conditions.

  • Moderate to Severe Plaque Psoriasis
  • Chronic Hand Eczema
  • Nonsegmental Vitiligo

By exploring new treatment modalities, the center aims to improve patient outcomes and quality of life for those affected by challenging dermatological disorders.

Endocrinology

Specializing in endocrinology, the medical center conducts advanced research on Type 2 Diabetes. The focus is on comparing the effectiveness of emerging treatments to existing standards, thereby enhancing therapeutic strategies for better glycemic control in patients.

  • Type 2 Diabetes

Through these studies, the center plays a pivotal role in developing more effective and patient-friendly diabetes management options.

Infectious Diseases

The center is actively involved in the study of infectious diseases, with a particular emphasis on recurrent herpes labialis. By comparing different antiviral formulations, the research aims to optimize treatment protocols and improve patient care.

  • Recurrent Herpes Labialis (RHL)

This research contributes to the development of more effective treatments, reducing the frequency and severity of outbreaks.

Cosmetic Dermatology

In the realm of cosmetic dermatology, the center is pioneering research on acne vulgaris. By testing new topical formulations, the center seeks to enhance the safety and efficacy of acne treatments, offering long-term solutions for patients.

  • Acne Vulgaris

These efforts are crucial in providing effective, sustainable treatment options for individuals struggling with acne.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Prezydenta Ryszarda Kaczorowskiego 7/u 5015-375 BialystokPoland
Recruiting now
8 trials
Conditions studied
16

More sites in BialystokPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

27 clinical trials

Psoriasis

Recruiting

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Psoriasis

Recruiting

Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Oral herpes

Recruiting

Study comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Laboratorios Ojer Pharma S.L.

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Obesity

Recruiting

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

Psoriasis

Not yet recruiting

Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen Cilag International

Dermatitis atopic

Not yet recruiting

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3454738
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Hidradenitis

Not recruiting

Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:CIT-013
  • Sponsor:Citryll B.V.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.